81 related articles for article (PubMed ID: 17726933)
1. Hypercoagulability based on thromboelastography is common in dogs undergoing adrenalectomy.
Mitsui A; Rosen S; Yaxley P; Lapsley J; Tremolada G; Selmic LE
J Am Vet Med Assoc; 2024 Jun; 262(6):1-6. PubMed ID: 38608654
[TBL] [Abstract][Full Text] [Related]
2. Iatrogenic symptomatic hypoadrenocorticism after treatment with trilostane for hyperadrenocorticism in dogs: eight cases (2008-2019).
Lamoureux A; Cadoré JL; Hugonnard M; Chabanne L; Krafft E
J Small Anim Pract; 2023 Jun; 64(6):409-414. PubMed ID: 36960837
[TBL] [Abstract][Full Text] [Related]
3. Canine hyperadrenocorticism associations with signalment, selected comorbidities and mortality within North American veterinary teaching hospitals.
Hoffman JM; Lourenço BN; Promislow DEL; Creevy KE
J Small Anim Pract; 2018 Nov; 59(11):681-690. PubMed ID: 30039567
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.
Arenas C; Melián C; Pérez-Alenza MD
J Vet Intern Med; 2014; 28(2):473-80. PubMed ID: 24495125
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic adrenalectomy for treatment of unilateral adrenocortical carcinomas: technique, complications, and results in seven dogs.
Jiménez Peláez M; Bouvy BM; Dupré GP
Vet Surg; 2008 Jul; 37(5):444-53. PubMed ID: 18986311
[TBL] [Abstract][Full Text] [Related]
6. Results of adrenalectomy in 36 dogs with hyperadrenocorticism caused by adreno-cortical tumour.
van Sluijs FJ; Sjollema BE; Voorhout G; van den Ingh TS; Rijnberk A
Vet Q; 1995 Sep; 17(3):113-6. PubMed ID: 8525598
[TBL] [Abstract][Full Text] [Related]
7. Results of surgical treatment for hyperadrenocorticism caused by adrenocortical neoplasia in the dog: 25 cases (1980-1984).
Scavelli TD; Peterson ME; Matthiesen DT
J Am Vet Med Assoc; 1986 Nov; 189(10):1360-4. PubMed ID: 3793588
[TBL] [Abstract][Full Text] [Related]
8. Update on the use of trilostane in dogs.
Lemetayer J; Blois S
Can Vet J; 2018 Apr; 59(4):397-407. PubMed ID: 29606727
[TBL] [Abstract][Full Text] [Related]
9. A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane.
Helm JR; McLauchlan G; Boden LA; Frowde PE; Collings AJ; Tebb AJ; Elwood CM; Herrtage ME; Parkin TD; Ramsey IK
J Vet Intern Med; 2011; 25(2):251-60. PubMed ID: 21352377
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of baseline cortisol, endogenous ACTH, and cortisol/ACTH ratio to monitor trilostane treatment in dogs with pituitary-dependent hypercortisolism.
Burkhardt WA; Boretti FS; Reusch CE; Sieber-Ruckstuhl NS
J Vet Intern Med; 2013; 27(4):919-23. PubMed ID: 23701195
[TBL] [Abstract][Full Text] [Related]
11. Treating canine Cushing's syndrome: Current options and future prospects.
Sanders K; Kooistra HS; Galac S
Vet J; 2018 Nov; 241():42-51. PubMed ID: 30340659
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of risk factors for outcome associated with adrenal gland tumors with or without invasion of the caudal vena cava and treated via adrenalectomy in dogs: 86 cases (1993-2009).
Barrera JS; Bernard F; Ehrhart EJ; Withrow SJ; Monnet E
J Am Vet Med Assoc; 2013 Jun; 242(12):1715-21. PubMed ID: 23725435
[TBL] [Abstract][Full Text] [Related]
13. Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs.
Macfarlane L; Parkin T; Ramsey I
Vet Rec; 2016 Dec; 179(23):597. PubMed ID: 27803375
[TBL] [Abstract][Full Text] [Related]
14. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism.
Griebsch C; Lehnert C; Williams GJ; Failing K; Neiger R
J Vet Intern Med; 2014; 28(1):160-5. PubMed ID: 24341822
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).
Behrend EN; Kooistra HS; Nelson R; Reusch CE; Scott-Moncrieff JC
J Vet Intern Med; 2013; 27(6):1292-304. PubMed ID: 24112317
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 1: Pathophysiology, aetiology, clinical and clinicopathological features.
Bennaim M; Shiel RE; Mooney CT
Vet J; 2019 Oct; 252():105342. PubMed ID: 31554593
[TBL] [Abstract][Full Text] [Related]
17. Hyperadrenocorticism: treating dogs.
Brown CG; Graves TK
Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
[TBL] [Abstract][Full Text] [Related]
18. Problems associated with medical therapy of canine hyperadrenocorticism.
Nichols R
Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
